Evaluation of antimicrobial prophylaxis in genital gender affirmation surgery
This study observed an acceptable prevalence of surgical site infections within both 30 days and 6 months of genital gender affirmation surgery. This outcome supports the use of narrow gram-positive and gram-negative coverage (ie, cefazolin) for clean and clean-contaminated procedures without entry into the gastrointestinal (GI) or gastroduodenal (GU) tracts, with the addition of anaerobic coverage (ie, metronidazole) for clean-contaminated procedures with entry into the GI or GU tract, as clinically appropriate options.
Authors
- Monica R. Macik (ORCID: https://orcid.org/0000-0002-6781-8216)
- Andrew C. Lodolo
- Mary Soyster (ORCID: https://orcid.org/0000-0001-6700-8662)
- David R. Foster (ORCID: https://orcid.org/0000-0003-1171-3762)
- Mary E. Blair (ORCID: https://orcid.org/0000-0003-0139-020X)
- Kerri E. Degenkolb
- Taylor Rhew
- Joshua D. Roth (ORCID: https://orcid.org/0000-0002-2990-2978)
- Lauren Schmidt (ORCID: https://orcid.org/0000-0002-6711-6636)
Institutions
- Indiana University Health (US)
- Purdue University West Lafayette (US)
- Eskenazi Health Foundation (US)
- Eskenazi Health
- Indiana University – Purdue University Indianapolis (US)
Publication Details
- Journal
- American Journal of Health-System Pharmacy
- Published
- 2025-03-13
- DOI
- https://doi.org/10.1093/ajhp/zxaf063
- Primary Topic
- Female Genital Mutilation/Cutting Issues
- Type
- article
- Field-Weighted Citation Impact
- 0.00